3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide

C22H28FN3O2 — CID 130254449

IUPAC3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide
SMILESCC1CC(NC(=O)C2=CC(N3CCN(C(=O)C4CC4)CC3)CC=C2)=CC=C1F
InChIInChI=1S/C22H28FN3O2/c1-15-13-18(7-8-20(15)23)24-21(27)17-3-2-4-19(14-17)25-9-11-26(12-10-25)22(28)16-5-6-16/h2-3,7-8,14-16,19H,4-6,9-13H2,1H3,(H,24,27)
InChIKeyDSJDEFINVAMBFC-UHFFFAOYSA-N
MW385.48 g/mol
LogP2.69
Rot. Bonds4

About 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide

3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide (PubChem CID 130254449) has the molecular formula C22H28FN3O2 and a molecular weight of 385.48 g/mol. Its IUPAC name is 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide.

Molecular Properties

Compound Name3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide
PubChem CID130254449
Molecular FormulaC22H28FN3O2
Molecular Weight385.48 g/mol
Exact Mass385.22
IUPAC Name3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide
SMILESCC1CC(NC(=O)C2=CC(N3CCN(C(=O)C4CC4)CC3)CC=C2)=CC=C1F
InChIInChI=1S/C22H28FN3O2/c1-15-13-18(7-8-20(15)23)24-21(27)17-3-2-4-19(14-17)25-9-11-26(12-10-25)22(28)16-5-6-16/h2-3,7-8,14-16,19H,4-6,9-13H2,1H3,(H,24,27)
InChIKeyDSJDEFINVAMBFC-UHFFFAOYSA-N
XLogP2.69
TPSA52.65 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500385.48
LogP ≤ 52.69
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide?
The IUPAC name of 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide (CID 130254449) is 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide.
What is the SMILES notation for 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide?
The canonical SMILES for 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide is CC1CC(NC(=O)C2=CC(N3CCN(C(=O)C4CC4)CC3)CC=C2)=CC=C1F.
What is the InChIKey of 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide?
The InChIKey is DSJDEFINVAMBFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H28FN3O2/c1-15-13-18(7-8-20(15)23)24-21(27)17-3-2-4-19(14-17)25-9-11-26(12-10-25)22(28)16-5-6-16/h2-3,7-8,14-16,19H,4-6,9-13H2,1H3,(H,24,27).
What are the key properties of 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide?
3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide has a molecular weight of 385.48 g/mol, XLogP of 2.69, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-fluoro-5-methylcyclohexa-1,3-dien-1-yl)cyclohexa-1,5-diene-1-carboxamide is sourced from PubChem (CID 130254449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).